The Drug Assessment Working Group (DAWG) is committed to analyze scientific evidence on the effectiveness and safety of drug therapies used in Canada. They systematically review and, when appropriate, critically appraise research relevant to new and existing drugs. Often the goal is to discover whether a new drug provides a therapeutic advantage over existing similar drug therapy for a clinical condition. The Therapeutics Initiative has a dedicated team of researchers that is committed to the highest standards of research. In addition to reports on various new and existing drugs (see list below for links to executive summaries), the DAWG also contributes to the federal Common Drug Review (CDR), a national program set up to reduce duplication, and provide equal access to high level evidence and expert advice, thereby contributing to the quality and sustainability of Canadian public drug plans. The DAWG has contributed to many of the CDR reviews. Click here to search the CDR Drug Database, with links to the executive summaries and recommendations.

Below is a list of completed DAWG reports with links to the executive summaries.

Date	Topic	View
06 Apr 2009	Clopidogrel for the treatment of adult patients following acute coronary syndrome	View
09 Feb 2009	Estradiol/levonorgestrel (Seasonale) for prevention of pregnancy	View
12 Jan 2009	Imiquimod cream for the treatment of adult patients with actinic keratosis	View
12 Jan 2009	Calcipotriol/betamethasone (Dovobet) ointment for the treatment of adult patients with psoriasis vulgaris	View
09 Jun 2008	Mesalamine for induction of remission in patients with active mild to moderate ulcerative colitis	View
12 May 2008	Levofloxacin for community acquired pneumonia	View
12 May 2008	Levofloxacin for acute exacerbations of chronic bronchitis	View
12 May 2008	Levofloxacin for acute bacterial sinusitis	View
14 Apr 2008	Moxifloxacin for community acquired pneumonia	View
14 Apr 2008	Moxifloxacin for acute exacerbations of chronic bronchitis	View
14 Apr 2008	Moxifloxacin for acute bacterial sinusitis	View
09 Jul 2007	Ezetimibe for the treatment of adult patients with hypercholesterolemia	View
11 Jun 2007	Olanzapine for maintenance therapy	View
11 Jun 2007	Low molecular weight heparins for secondary prevention of symptomatic venous thromboembolism in patients with cancer	View
11 Jun 2007	Clopidogrel after drug-eluting stent implantation	View
14 May 2007	Olanzapine for the treatment of adult patients with acute mania	View
16 Apr 2007	Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart disease	View
12 Mar 2007	Interferon beta-1b for clinically isolated syndrome (multiple sclerosis)	View
12 Mar 2007	Insulin aspart for diabetes mellitus	View
12 Mar 2007	Gliclazide for type 2 diabetes mellitus	View
12 Mar 2007	Dalteparin for extended treatment of symptomatic venous thromboembolism in patients with cancer	View
12 Feb 2007	Insulin lispro for diabetes mellitus	View
20 Nov 2006	Somatropin (Nutropin) for patients with adult growth hormone deficiency	View
12 Dec 2005	Oral delta-9-THC (Marinol) for AIDS-related anorexia/weight loss	View